ArticleOncotarget2016
Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma.
Judith Hagenbuchner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it
ArticleOncotarget2016
Judith Hagenbuchner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.